A critical advance in cancer study is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial tumor suppressor protein is frequently disabled in several types of malignancies, leading https://apollobookmarks.com/story21879550/nanobodies-revive-tumor-suppressor-p53-new-new-pathway-for-malignant-therapy